Cuproptosis-related lncRNA predict prognosis and immune response of lung adenocarcinoma.

Wang, Fangwei; Lin, Hongsheng; Su, Qisheng; Li, Chaoqian

Wang, Fangwei; Lin, Hongsheng; Su, Qisheng; Li, Chaoqian.

Wang F; Department of Respiratory Medicine, The First Affiliated Hospital of Guangxi Medical University, Nan'ning, China.
Lin H; Department of Microbiology, School of Basic Medical Sciences, Guangxi Medical University, Nan'ning, China.
Su Q; Department of Clinical Laboratory, The First Affiliated Hospital of Guangxi Medical University, Nan'ning, China.
Li C; Department of Respiratory Medicine, The First Affiliated Hospital of Guangxi Medical University, Nan'ning, China. lichaoqiangood@163.com.

World J Surg Oncol ; 20(1): 275, 2022 Sep 01.

Article en En | MEDLINE | ID: mdl-36050740

Asunto(s)

Adenocarcinoma del Pulmón; Apoptosis; Neoplasias Pulmonares; ARN Largo no Codificante; Humanos; Adenocarcinoma del Pulmón/genética; Adenocarcinoma del Pulmón/inmunología; Inmunidad; Estimación de Kaplan-Meier; Neoplasias Pulmonares/genética; Neoplasias Pulmonares/inmunología; Pronóstico; ARN Largo no Codificante/genética; ARN Largo no Codificante/metabolismo; Cobre

Palabras clave

Cuproptosis; Drug sensitivity; Immune; Prognosis; Signature; lncRNAs

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Apoptosis / ARN Largo no Codificante / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google